RGN - RegeneRx Biopharmaceuticals Incorporated

$0.66 0.06 | 10.00%
Today's Range: 0.62 - 0.66
RGN Avg. Daily Volume: 191,700
12/09/09 - 3:58 PM ET
TRADE NOW
Company Income Statement
Dec 2008 Dec 2007 Dec 2006 Dec 2005
Sales 168.41K 240.32K 272.49K 0.00
Cost of Sales -19.40K -21.20K -18.11K -15.63K
Gross Operating Profit 187.81K 261.52K 290.60K 15.63K
Selling, General, and Administrative Expenses 3.85M 3.20M 2.67M 1.64M
Research & Development 7.11M 8.89M 6.40M 4.03M
Operating Income before D & A (EBITDA) -10.77M -11.82M -8.77M -5.65M
Depreciation & Amortization 19.40K 21.20K 18.11K 15.63K
Interest Income 149.78K 666.46K 522.70K 214.68K
Other Income - Net 0.00 0.00 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -10.64M -11.18M -8.27M -5.45M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -10.64M -11.18M -8.27M -5.45M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -10.64M -11.18M -8.27M -5.45M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -10.64M -11.18M -8.27M -5.45M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -10.64M -11.18M -8.27M -5.45M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-10.64M -11.18M -8.27M -5.45M
Preferred Dividends
Net Income Available To Common -10.64M -11.18M -8.27M -5.45M
Basic EPS from Continuing Ops. -0.21 -0.24 -0.21 -0.15
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.21 -0.24 -0.21 -0.15
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.21 -0.24 -0.21 -0.15
Basic Normalized Net Income/Share -0.21 -0.24 -0.21 -0.15
EPS fr Continuing Ops. -0.21 -0.24 -0.21 -0.15
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.21 -0.24 -0.21 -0.15
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.21 -0.24 -0.21 -0.15
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.21 -0.24 -0.21 -0.15
Dividends Paid per Share 0.00 0.00 0.00 0.00
Latest RGN Headlines

Brokerage Partners

TheStreet Premium Services

All Services